Universe Pharmaceuticals INC (UPC) stock
UPCNasdaqPharmaceutical PreparationsFiscal year ends September 30
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Sep 30, 2025Last filing: 20-F on Jan 29, 2026Score 5/30
$1.56+0.08 (+5.41%)
Close on Nov 17, 2026Market cap $878.81KP/E –Yield –
Universe Pharmaceuticals gross margin
Gross margin is gross profit as a percentage of revenue.
For fiscal 2025 it was 35.3%, against 26.4% the year before. The highest annual figure on record is 54.5% in fiscal 2022.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | 35.3% | +8.9 |
| FY2024 | Sep 30, 2024 | 26.4% | −5.6 |
| FY2023 | Sep 30, 2023 | 31.9% | −22.6 |
| FY2022 | Sep 30, 2022 | 54.5% | +1.8 |
| FY2021 | Sep 30, 2021 | 52.8% | +6.9 |
| FY2020 | Sep 30, 2020 | 45.9% | +5.6 |
| FY2019 | Sep 30, 2019 | 40.3% | – |
See a number that looks wrong?